The VHPB endorses the European meeting on HIV & Hepatitis 2024 - Treatment Strategies & Antiviral Drug Resistance (22-24 May 2024, Barcelona, Spain).

The VHPB endorses the International Viral Hepatitis Elimination Meeting, 1-2 December 2023, Amsterdam, the Netherlands.

Based on the VHPB technical meeting on the changing context of hepatitis Delta (28-29 Oct 2021), a number of VHPB advisor, together with the VHPB scientific secretariat have written a maniscript entitled: The elimination of hepatitis D as a public health problem: Needs and challenges.

Gavi, the Vaccine Alliance, resumes support for hepatitis B vaccination of newborns in Africa. 

Following VHPB meeting materials are now available online:

1. Elimination of Viral Hepatitis in the Balkan countries: Lessons Learnt and the way forward, Skopje (North Macedonia), 27-28 October 2022

• The meeting objectives
• The background document
• The agenda, including all presentations
• The meeting conclusions as presented during the meeting
• The meeting report

The VHPB endorses the HepHIV2023 Conference.

HepHIV2023 Conference: Progress and implementation of integrated testing, new technologies and ensuring equity in the delivery of HIV, viral hepatitis and STI services, 13-15 November 2023, Madrid, Spain.

The VHPB endorses the European Meeting on HIV & Hepatitis 2023.

The VHPB works closely with the European Liver Patients’ Association (ELPA). In our most recent meeting: The Elimination of Viral Hepatitis in the Balkan Countries, we were able to invite several representatives from local patient organizations through ELPA, which was a great added value for the meeting.

There is a permanent seat in the VHPB board for a representative from ELPA, which is currently occupied by EPLA president Marko Korenjak.

WHO position paper on hepatitis A vaccines - WHO/SAGE working group on hepatitis A